Cited by 62Cancer Cells and MetastasisSingle-cell and spatial transcriptomicsClick Chemistry and Applications

An in vivo multiplexed small-molecule screening platform

Open access
Grüner, Barbara M, Schulze, Christopher J, Yang, Dian, Ogasawara, Daisuke, Dix, Melissa M, Rogers, Zoë N, Chuang, Chen-Hua, McFarland, Christopher D +5 more·2016·Nature Methods

Abstract

Phenotype-based small-molecule screening is a powerful method to identify molecules that regulate cellular functions. However, such screens are generally performed in vitro under conditions that do not necessarily model complex physiological conditions or disease states. Here, we use molecular cell barcoding to enable direct in vivo phenotypic screening of small-molecule libraries. The multiplexed nature of this approach allows rapid in vivo analysis of hundreds to thousands of compounds. Using this platform, we screened >700 covalent inhibitors directed toward hydrolases for their effect on pancreatic cancer metastatic seeding. We identified multiple hits and confirmed the relevant target of one compound as the lipase ABHD6. Pharmacological and genetic studies confirmed the role of this enzyme as a regulator of metastatic fitness. Our results highlight the applicability of this multiplexed screening platform for investigating complex processes in vivo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nmeth.3992

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A multiplexed in vivo screening platform was developed in which barcoded pancreatic ductal adenocarcinoma lines were pretreated with electrophilic compounds and injected into mice to observe compound-dependent decrease in metastatic potential.

    “a multiplexed in vivo screening platform was developed in which barcoded pancreatic ductal adenocarcinoma lines were pretreated with electrophilic compounds and injected into mice to observe the compound-dependent decrease in metastatic potential186.”

    From Advances in covalent drug discovery (2022) · cites this paper as [186]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Grüner, B. M., Schulze, C. J., Yang, D., Ogasawara, D., Dix, M. M., Rogers, Z. N., Chuang, C.-H., McFarland, C. D., Chiou, S.-H., Brown, J. M., Cravatt, B. F., Bogyo, M., & Winslow, M. M.
Affiliations
  • Stanford Medicine (US)
  • Scripps Research Institute (US)
  • Stanford University (US)
  • Cleveland Clinic (US)
Corresponding author
  • Bogyo, Matthew
  • Winslow, Monte M
Venue
Nature Methods
Published
2016-09-12
Volume
13
Issue
10
Pages
883-889
ISSN
  • 1548-7091 (ISSN-L)
  • 1548-7105
OpenAlex
W2519825823
Cited by
62
References
49
Citations by year
2026: 2 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 10 · 2021: 13 · 2020: 6 · 2019: 8 · 2018: 6 · 2017: 4
FWCI
3.24
Type
journal article
Language
en
Open access
Locations
  • Nature Methods (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Rutgers University Community Repository (Rutgers University) (submittedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL122283)
  • National Institute on Drug Abuse (R01DA033760)
  • National Cancer Institute (R21CA188863, R25CA180993, F32CA200078, R01CA132630, P30CA124435)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
Keywords
phenotypic screening, metastatic seeding, pancreatic cancer metastasis, ABHD6, lipase
MeSH terms
Animals, Cell Adhesion, Cell Movement, Dose-Response Relationship, Drug, Drug Evaluation, Preclinical, Humans, Liver Neoplasms, Monoacylglycerol Lipases, Neoplasm Transplantation, Pancreatic Neoplasms, Mice, SCID, Cell Line, Tumor, Cell Proliferation, Mice, Small Molecule Libraries, Gene Knockdown Techniques, Molecular Imaging, High-Throughput Screening Assays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review